Pain in Guillain-Barre syndrome

Neurology

Volumn 48, Issue 2, 1997, Pages 328-331

  Moulin, D E ^a,c   Hagen, N ^b   Feasby, T E ^b   Amireh, R ^a   Hahn, A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SYNDROME DELINEATION;

EID: 0031035513     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.328     Document Type: Article

References (24)

1. Haymaker W, Kernohan JW. Landry-Guillain-Barré syndrome: a clinicopathological report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141.
2. Asbury A, Arnason B, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969;48:173-215.
3. Loffel NB, Rossi LN, Mumenthaler M, Lutschg J, Ludin HP. The Landry-Guillain-Barré syndrome: complications, prognosis, and natural history in 123 cases. J Neurol Sci 1977;33:71-79.
4. Samantray SK, Johnson SC, Mathai KV, Pulimood BM. Landry-Guillain-Barré syndrome: a study of 302 cases. Med J Aust 1977;2:84-91.
5. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51: 605-612.
6. De Jager AE, Sluiter HJ. Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients. J Neurol Sci 1991; 104:143-150.
7. Ng KKP, Howard RS, Fish DR, et al. Management and outcome of severe Guillain-Barré syndrome. Q J Med 1995;88: 243-250.
8. Hughes RAC, Winer JB. Guillain-Barré syndrome. In: Matthews WB, Glaser GH, eds. Recent advances in clinical neurology, vol 4. Edinburgh: Churchill Livingstone, 1984:19-49.
9. Ropper AH, Shahani BT. Pain in Guillain-Barré syndrome. Arch Neurol 1984;41:511-514.
10. Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):1-5.
11. Hughes R, Sanders E, Hall S, Atkinson P, Colchester A, Payan P. Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 1992;49:612-616.
12. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDF). Neurology 1991;41:617-618.
13. Merskey H, Albe-Fessard DG, Bonica JJ, et al. Pain terms: a list with definitions and notes on usage. Pain 1979;6:249-252.
14. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
15. Hahn AF, Bolton CF, Pillay N, et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, crossover study. Brain 1996; 119:1055-1066.
16. Graves DA, Foster TS, Batenhorst RL, Bennett RL, Baumann TJ. Patient-controlled analgesia. Ann Intern Med 1983;99: 360-366.
17. Clague, JE, MacMillan RR. Backache and the Guillain-Barré syndrome: a diagnostic problem. BMJ 1986;293:325-326.
18. Asbury AK, Fields HL. Pain due to peripheral nerve damage: an hypothesis. Neurology 1984;34:1587-1590.
19. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome Philadelphia: FA Davis, 1991.
20. Pentland B, Donald SM. Pain in the Guillain-Barré syndrome: a clinical review. Pain 1994;59:159-164.
21. Moulin DE, Iezzi A, Amireh R, Sharpe WKJ, Boyd D, Merskey H. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143-147.
22. Rosenfeld B, Borel C, Hanley D. Epidural morphine treatment of pain in Guillain-Barré syndrome. Arch Neurol 1986,43: 1194-1196.
23. Genis D, Busquets C, Manubens E, Dávalos A, Barø J, Oterino A. Epidural morphine analgesia in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1989;52.999-1001.
24. Yaksh TL. Spinal opiate analgesia: characteristics and principles of action. Pain 1981;11:293-346.